Market Overview

15 Biggest Mid-Day Losers For Friday

Share:
  • Pluristem Therapeutics Inc. (NASDAQ: PSTI) shares dipped 22.9 percent to $1.08. Pluristem disclosed that it has increased its bought deal offering to $15 million of stock and warrants.
  • Affimed NV (NASDAQ: AFMD) shares fell 20.9 percent to $1.70. Affimed priced its public offering of 10,000,000 of its common shares at $1.80 per common share.
  • Uranium Resources, Inc. (NASDAQ: URRE) dropped 14.6 percent to $2.29 after the company reported a closing of $9.7 million public offering.
  • NF Energy Saving Corp (NASDAQ: NFEC) shares fell 14 percent to $1.10. On Thursday, NF Energy Saving reported a business cooperation with an Indian company.
  • Naked Brand Group Inc (NASDAQ: NAKD) declined 13.7 percent to $1.83. Naked Brand shares have dropped 22.06 percent over the past 52 weeks, while the S&P 500 index has gained 21.75 percent in the same period.
  • Delta Technology Holdings Limited (NASDAQ: DELT) shares fell 13.3 percent to $1.50. On Thursday, Delta Technology posted a surge in sales for the fourth quarter.
  • Bristol-Myers Squibb Co (NYSE: BMY) shares declined 9.5 percent to $50.21 after the company reported that it will not be pursuing accelerated regulatory approval for its lung cancer drug Opvido/Yervoy.
  • Gravity Co., LTD. (ADR) (NASDAQ: GRVY) dropped 7.8 percent to $19.33 after rising 23.11 percent on Thursday.
  • Synergy Pharmaceuticals Inc (NASDAQ: SGYP) declined 6.7 percent to $5.98. The U.S. Food and Drug Administration said it approved the company’s plecanatide, branded as Trulance, for the treatment of chronic idiopathic constipation.
  • Intercept Pharmaceuticals Inc (NASDAQ: ICPT) dropped 4.1 percent to $109.95. Needham downgraded Intercept Pharmaceuticals from Buy to Hold.
  • Abraxas Petroleum Corp. (NASDAQ: AXAS) shares slipped 4.1 percent to $2.58. Abraxas Petroleum priced its 25 million share offering at $2.40 per share.
  • Herbalife Ltd. (NYSE: HLF) shares dropped 3.4 percent to $51.35. Herbalife issued disappointing earnings outlook for FY2017.
  • Stemline Therapeutics Inc (NASDAQ: STML) declined 3.2 percent to $10.65 after the company reported a proposed public offering of common stock.
  • Equifax Inc. (NYSE: EFX) slipped 2.2 percent to $117.54. Goldman Sachs downgraded Equifax from Neutral to Sell.
  • General Electric Company (NYSE: GE) shares fell 2.1 percent to $30.56. General Electric reported in-line earnings for its latest quarter, but sales missed expectations.

Latest Ratings for PSTI

DateFirmActionFromTo
Jul 2018Initiates Coverage OnBuy
Oct 2017Initiates Coverage OnBuy
Jun 2017UpgradesHoldBuy

View More Analyst Ratings for PSTI
View the Latest Analyst Ratings

Posted-In: Mid-Day LosersNews Movers & Shakers Intraday Update Markets Analyst Ratings

 

Related Articles (AXAS + AFMD)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
WUBABOCOM InternationalDowngrades
DLTROTR GlobalUpgrades
ARCCCompass PointDowngrades
GTYHCitiInitiates Coverage On7.0
NKEGuggenheimMaintains100.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Don't Get Too Excited About Biogen's Q4 Earnings

The 2017 Forecast On Financials: A Conversation With Community Bank Analyst Chris Marinac, Part Two